Source: Neuro-Oncology. Conference titles: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Subjects: TUMOR CARCINOIDE, GLÂNDULA PITUITÁRIA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Ana Valéria et al. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.080. Acesso em: 02 out. 2024. , 2019APA
Castro, A. V., Wells, M., Asmaro, K., Sabedot, T. S., Mosella, M. S., Malta, T. M., et al. (2019). Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.080NLM
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, Carvalho A de, Noushmehr H. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii24.[citado 2024 out. 02 ] Available from: https://doi.org/10.1093/neuonc/noz126.080Vancouver
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, Carvalho A de, Noushmehr H. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii24.[citado 2024 out. 02 ] Available from: https://doi.org/10.1093/neuonc/noz126.080